총 50 건의 최근 내부자 거래 내역가 기록되었습니다 Actinium Pharmaceuticals, Inc. (ATNM), 포함 41 건 매수 및 8 건 매도. 내부자 매수 총액은 $16.44M 내부자 매도 총액은 $2.15M.
최근 활동이 있는 주요 내부자에는 Seth Sandesh, Steinhart Richard I, Almenoff June Sherie. 내부자 거래 내역는 경영진이 주식의 가치와 미래 전망을 어떻게 보는지에 대한 통찰을 제공할 수 있습니다.
내부자 거래 내역 — ATNM
| 날짜 |
이름 |
직책 |
거래 유형 |
주식수 |
평균 가격 |
금액 |
보유 주식수 |
| 2025-08-18 |
Seth Sandesh |
Chief Executive Officer |
RSU 원천징수 |
120,900 |
$1.71 |
$206.74K |
184,481 |
| 2025-03-31 |
Steinhart Richard I |
Director |
주식 반환 |
2,500 |
$59.70 |
$149.25K |
- |
| 2025-03-31 |
Almenoff June Sherie |
Director |
주식 반환 |
50,000 |
$1.71 |
$85.5K |
- |
| 2025-03-31 |
Seth Sandesh |
Chief Executive Officer |
주식 반환 |
33,333 |
$23.49 |
$782.99K |
- |
| 2025-03-31 |
O'loughlin Steve |
Chief Financial Officer |
주식 반환 |
3,333 |
$41.70 |
$138.99K |
- |
| 2025-03-31 |
Nicholson, C. David |
Director |
주식 반환 |
70,311 |
$5.00 |
$351.56K |
- |
| 2025-03-31 |
Shetty Ajit |
Director |
주식 반환 |
72,156 |
$4.96 |
$357.89K |
- |
| 2025-03-31 |
Chell Jeffrey W. |
Director |
주식 반환 |
8,333 |
$9.55 |
$79.58K |
- |
| 2024-11-01 |
Almenoff June Sherie |
Director |
알 수 없음 |
- |
- |
- |
- |
| 2024-11-01 |
Almenoff June Sherie |
Director |
RSU 부여 |
50,000 |
$1.71 |
$85.5K |
50,000 |
| 2023-12-28 |
Steinhart Richard I |
Director |
RSU 부여 |
70,311 |
$5.00 |
$351.56K |
70,311 |
| 2023-12-28 |
Seth Sandesh |
Chief Executive Officer |
RSU 부여 |
984,367 |
$5.00 |
$4.92M |
984,367 |
| 2023-12-28 |
O'loughlin Steve |
Chief Financial Officer |
RSU 부여 |
253,123 |
$5.00 |
$1.27M |
253,123 |
| 2023-12-28 |
Nicholson, C. David |
Director |
RSU 부여 |
70,311 |
$5.00 |
$351.56K |
70,311 |
| 2023-12-28 |
Shetty Ajit |
Director |
RSU 부여 |
70,311 |
$5.00 |
$351.56K |
70,311 |
| 2023-12-28 |
Chell Jeffrey W. |
Director |
RSU 부여 |
70,311 |
$5.00 |
$351.56K |
70,311 |
| 2022-08-17 |
Seth Sandesh |
Chief Executive Officer |
RSU 부여 |
300,000 |
- |
- |
305,381 |
| 2022-07-01 |
Steinhart Richard I |
Director |
RSU 부여 |
72,156 |
- |
- |
72,156 |
| 2022-07-01 |
Seth Sandesh |
Chief Executive Officer |
RSU 부여 |
827,366 |
- |
- |
827,366 |
| 2022-07-01 |
O'loughlin Steve |
Chief Financial Officer |
RSU 부여 |
256,438 |
$4.96 |
$1.27M |
256,348 |
| 2022-07-01 |
Nicholson, C. David |
Director |
RSU 부여 |
72,156 |
- |
- |
72,156 |
| 2022-07-01 |
Shetty Ajit |
Director |
RSU 부여 |
72,156 |
- |
- |
72,156 |
| 2022-07-01 |
Chell Jeffrey W. |
Director |
RSU 부여 |
72,156 |
- |
- |
72,156 |
| 2021-09-01 |
Steinhart Richard I |
Director |
RSU 부여 |
18,351 |
$6.07 |
$111.39K |
18,351 |
| 2021-09-01 |
Seth Sandesh |
Chief Executive Officer |
RSU 부여 |
310,182 |
$6.07 |
$1.88M |
310,182 |
| 2021-09-01 |
O'loughlin Steve |
Chief Financial Officer |
RSU 부여 |
107,463 |
$6.07 |
$652.3K |
107,463 |
| 2021-09-01 |
Nicholson, C. David |
Director |
RSU 부여 |
18,351 |
$6.07 |
$111.39K |
18,351 |
| 2021-09-01 |
Shetty Ajit |
Director |
RSU 부여 |
18,351 |
$6.07 |
$111.39K |
18,351 |
| 2021-09-01 |
Berger Mark Stanley |
Chief Medical Officer |
RSU 부여 |
67,164 |
$6.07 |
$407.69K |
67,164 |
| 2021-09-01 |
Chell Jeffrey W. |
Director |
RSU 부여 |
18,351 |
$6.07 |
$111.39K |
18,351 |
| 2020-08-12 |
Steinhart Richard I |
Director |
RSU 부여 |
8,333 |
$9.55 |
$79.58K |
8,333 |
| 2020-08-12 |
Seth Sandesh |
Chief Executive Officer |
RSU 부여 |
139,062 |
$9.55 |
$1.33M |
139,062 |
| 2020-08-12 |
O'loughlin Steve |
Chief Financial Officer |
RSU 부여 |
59,066 |
$9.55 |
$564.08K |
59,066 |
| 2020-08-12 |
Nicholson, C. David |
Director |
RSU 부여 |
8,333 |
$9.55 |
$79.58K |
8,333 |
| 2020-08-12 |
Shetty Ajit |
Director |
RSU 부여 |
8,333 |
$9.55 |
$79.58K |
8,333 |
| 2020-08-12 |
Berger Mark Stanley |
Chief Medical Officer |
RSU 부여 |
46,667 |
$9.55 |
$445.67K |
46,667 |
| 2020-08-12 |
Ludwig Dale L. |
Chief Science & Tech. Officer |
RSU 부여 |
50,000 |
$9.55 |
$477.5K |
50,000 |
| 2020-08-12 |
Chell Jeffrey W. |
Director |
RSU 부여 |
8,333 |
$9.55 |
$79.58K |
8,333 |
| 2019-07-12 |
Steinhart Richard I |
Director |
RSU 부여 |
250,000 |
$0.23 |
$58K |
250,000 |
| 2019-07-12 |
Seth Sandesh |
CEO |
RSU 부여 |
1,500,000 |
$0.23 |
$348K |
1,500,000 |
| 2019-07-12 |
O'loughlin Steve |
Principal Financial Officer |
RSU 부여 |
400,000 |
$0.23 |
$92.8K |
400,000 |
| 2019-07-12 |
Nicholson, C. David |
Director |
RSU 부여 |
250,000 |
$0.23 |
$58K |
250,000 |
| 2019-07-12 |
Shetty Ajit |
Director |
RSU 부여 |
250,000 |
$0.23 |
$58K |
250,000 |
| 2019-07-12 |
Berger Mark Stanley |
Chief Medical Officer |
RSU 부여 |
400,000 |
$0.23 |
$92.8K |
400,000 |
| 2019-07-12 |
Ludwig Dale L. |
Chief Scientific Officer |
RSU 부여 |
400,000 |
$0.23 |
$92.8K |
400,000 |
| 2019-07-12 |
Kapur Anil |
Chief Commercial Officer |
RSU 부여 |
400,000 |
$0.23 |
$92.8K |
400,000 |
| 2019-07-12 |
Chell Jeffrey W. |
Director |
RSU 부여 |
250,000 |
$0.23 |
$58K |
250,000 |
| 2019-03-05 |
Berger Mark Stanley |
Chief Medical Officer |
옵션 행사 (ITM) |
3,500 |
$0.60 |
$2.1K |
22,500 |
| 2019-02-21 |
Seth Sandesh |
Chairman & CEO |
옵션 행사 (ITM) |
8,125 |
$0.60 |
$4.88K |
161,458 |
| 2018-12-10 |
Seth Sandesh |
Chairman & CEO |
정보 매수 |
10,000 |
$0.44 |
$4.37K |
153,333 |
■ 정보 기반 — 공개 시장 거래 (가장 중요)
■ 비정보 매수 — 보상, 옵션 행사, 전환
■ 비정보 매도 — 세금 원천징수, 부여 매도
■ 중립 — 증여, 신탁, 만료